Ketamine (KET) analogs are increasingly emerging as new psychoactive substances (NPS). The present report describes the first detection of the KET analog, 2‐fluorodeschloroketamine (2F‐DCK), in influent samples collected from nine wastewater treatment plants in seven major Chinese cities from 2018 to 2020 by wastewater‐based epidemiology (WBE). An analytical method based on solid‐phase extraction and subsequent gas chromatography–mass spectrometry was developed for the detection of 2F‐DCK and KET. The stability experiments showed that 2F‐DCK and KET remained stable in wastewater for 15 days at room and frozen temperatures, and at two pH values (pH = 7 and pH = 2), with residue amounts between 90% and 110%. KET was detected in all samples, whereas 2F‐DCK was detected in only four samples: from Guangzhou in 2018, Shenzhen in 2019, and Quanzhou and Nanning in 2020, indicating that 2F‐DCK has been used as early as 2018 in China. The renal clearance of 2F‐DCK was predicted based on the quantitative structure–pharmacokinetic relationship model, which was used to calculate an excretion factor of 3.7. The 2F‐DCK consumption in four cities ranged from 3.71 ± 0.05 to 55 ± 0.09 mg/day/1000 inh, and KET ranged from 1.3 ± 0.04 to 76.5 ± 4.63 mg/day/1000 inh. This is the first study to investigate 2F‐DCK by WBE, which provides relevant real‐time data on the growth of NPS use, as well as useful information for the government to develop new policies.